Effect of super-selective prostatic artery emboliation in the treatment of ultra-large benign prostate hyperplasia

doi:10.3877/cma.j.issn.1674-3253.2021.05.005

Abstract

Abstract:

Objective

To explore the safty and efficacy of super-selective prostatic artery embolization (PAE) in the treatment of ultra-large (≥120 ml) benign prostate hyperplasia.

Methods

The clinical data of 18 patients with ultra-large benign prostate hyperplasia treated with PAE in the First Hospital of Shanxi Medical University from August 2018 to December 2019 were analyzed retrospectively. The prostate volume (PV),international prostate symptom score (IPSS), quality of life (QOL), maximum urinary flow rate (Q_max) and residual urine volume (RUV) were compared before and 1, 3, and 6 months after surgery, and the operation complications were observed.

Results

The operation time of PAE in 18 patients with benign prostatic hyperplasia was 95-190 min, and the median operation time was 130 min. After the operation, 4 cases developed mild pubic pain and urethral burning, 2 cases developed transient hematuria, and 3 cases developed fever. 12 patients were successfully removed the urinary catheter on the third day after surgery. After the urinary catheter was removed, they could urinate spontaneously. The remaining 6 patients had the urinary catheter removed from 10 to 21 days after surgery. No serious complications occurred in all patients. The patients' PV, IPSS, QOL and RUV were significantly lower than those before surgery at 1, 3, and 6 months after surgery, and Q_max was significantly higher than before surgery, the difference was statistically significant (P<0.05).

Conclusion

PAE is safe and effective in treating ultra-large benign prostate hyperplasia. And PAE can be used as a surgical method for the treatment of ultra-large benign prostate hyperplasia in clinic.

Key words: Super-selective, prostatic artery embolization, Large volume, benign prostate hyperplasia, Uroclynamics

Haiyang Kuai, Zhifang Ma, Duiping Feng, Lichong Yu, Tiankun Hang, Mingkai Shi. Effect of super-selective prostatic artery emboliation in the treatment of ultra-large benign prostate hyperplasia[J]. Chinese Journal of Endourology(Electronic Edition), 2021, 15(05): 383-387.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhqjmnmwkzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-3253.2021.05.005

https://zhqjmnmwkzz.cma-cmc.com.cn/EN/Y2021/V15/I05/383

Figures/Tables 2

References 17

[1]	Roehrborn CG. Current medical therapies for men with lower urinary tract symptoms and benign prostatic hyperplasia: achievements and limitations[J]. Rev Urol, 2008, 10 (1): 14-25.
[2]	Rieken M, Herrmann TRW, Füllhase C. Operative Therapie des benignen Prostatasyndroms-resezieren, vaporisieren oder enukleieren?[J]. Der Urologe, 2019, 58(4): 1-7.
[3]	李笑, 曹德宏, 任正举, 等. 前列腺增生的激光微创治疗研究进展[J/CD].中华腔镜泌尿外科杂志（电子版）, 2020, 14(5): 397-400.
[4]	Pisco J, Campos Pinheiro L, Bilhim T, et al. Prostatic arterial embolization for benign prostatic hyperplasia: short-and intermediate-term results[J]. Radiology, 2013, 266(2): 668-677.
[5]	Angle JF, Siddiqi NH, Wallace MJ, et al. Quality improvement guidelines for percutaneous transcatheter embolization: society of interventional radiology standards of practice committee[J]. J Vasc Interv Radiol, 2010, 21(10): 1479-1486.
[6]	Cizman Z, Isaacson A, Burke C. Short-to midterm safety and efficacy of prostatic artery embolization: a systematic review[J]. J Vasc Interv Radiol, 2016, 27(10): 1487-1493.
[7]	DeMeritt JS, Elmasri FF, Esposito MP, et al. Relief of benign prostatic hyperplasia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostate embolization[J]. J Vasc Interv Radiol, 2000, 11(6): 767-770.
[8]	高元安, 张瑞, 冯安宝, 等.动脉栓塞治疗前列腺增生12例[J].中华放射学杂志, 2006, 40(12): 1314-1316.
[9]	Grosso M, Balderi A, Arnò M, et al. Prostatic artery embolization in benign prostatic hyperplasia: preliminary results in 13 patients[J]. Radiol Med, 2015, 120(4): 361-368.
[10]	Christidis D, Clarebrough E, Ly V, et al. Prostatic artery embolization for benign prostatic obstruction: assessment of safety and efficacy[J]. World J Urol, 2018, 36(4): 575-584.
[11]	Malling B, Røder MA, Brasso K, et al. Prostate artery embolisation for benign prostatic hyperplasia: a systematic review and meta-analysis[J]. Eur Radiol. 2019, 29(1): 287-298.
[12]	Carnevale FC, Moreira AM, de Assis AM, et al. Prostatic artery embolization for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: 10 years' experience[J]. Radiology, 2020, 296(2): 444-451.
[13]	Sun F, Crisóstomo V, Báez-Díaz C, et al. Prostatic Artery Embolization (PAE) for Symptomatic Benign Prostatic Hyperplasia (BPH): Part 2, Insights into the Technical Rationale[J]. Cardiovasc Intervent Radiol,2016,39(2):161-169.
[14]	Picel AC, Hsieh TC, Shapiro RM, et al. Prostatic artery embolization for benign prostatic hyperplasia: patient evaluation, anatomy, and technique for successful treatment[J]. Radiographics, 2019, 39(5): 1526-1548.
[15]	袁冰, 张金龙, 袁凯, 等. 超选择性前列腺动脉栓塞术治疗巨大前列腺增生所致下尿路阻塞的价值[J]. 中华放射学杂志, 2018, 52(3): 223-227.
[16]	吴少杰, 方主亭, 蔡森林, 等. 分析前列腺动脉栓塞治疗前列腺增生操作者学习曲线[J]. 中国介入影像与治疗学, 2019, 16(7): 410-414.
[17]	Bilhim T, Pisco J, Rio Tinto H, et al. Unilateral versus bilateral prostatic arterial embolization for lower urinary tract symptoms in patients with prostate enlargement[J]. Cardiovasc Intervent Radiol, 2013, 36(2): 403-411.

	PV(ml)	IPSS(分)	QOL(分)	Q_max(ml/s)	RUV(ml)
术前	168.12±35.250	29.88±2.39⁰	5.29±0.69⁰	⁰6.20±0.90	136.18±42.010⁰
术后1个月	121.29±29.19^a	11.24±1.60^a	2.94±0.75^a	11.46±1.01^a	75.29±29.02^a
术后3个月	097.24±17.96^b	07.12±1.27^b	2.11±0.60^b	13.95±0.99^b	48.24±24.87^b
术后6个月	090.76±14.53^c	06.53±1.23^c	1.88±0.60^c	15.16±1.14^c	33.82±18.84^c
F值	147.16	1284.30	188.00	317.17	104.65
P值	<0.001	<0.001	<0.001	<0.001	<0.001

	PV(ml)	IPSS(分)	QOL(分)	Q_max(ml/s)	RUV(ml)
术前	168.12±35.250	29.88±2.39⁰	5.29±0.69⁰	⁰6.20±0.90	136.18±42.010⁰
术后1个月	121.29±29.19^a	11.24±1.60^a	2.94±0.75^a	11.46±1.01^a	75.29±29.02^a
术后3个月	097.24±17.96^b	07.12±1.27^b	2.11±0.60^b	13.95±0.99^b	48.24±24.87^b
术后6个月	090.76±14.53^c	06.53±1.23^c	1.88±0.60^c	15.16±1.14^c	33.82±18.84^c
F值	147.16	1284.30	188.00	317.17	104.65
P值	<0.001	<0.001	<0.001	<0.001	<0.001

Please choose a citation manager

Content to export